(Q43118105)

14 November 2017

title

Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP. (English)

1 reference

14 November 2017

1 reference

S Koehrer

1

1 reference

14 November 2017

M J Keating

series ordinal

2

1 reference

14 November 2017

W G Wierda

series ordinal

3

1 reference

14 November 2017

publication date

25 March 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

24

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

1096-1098

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.45

14 November 2017

exact match

0 references

cites work

Disease-specific complications of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.45

The ITP syndrome: pathogenic and clinical diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.45

Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.45

New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.45

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.45

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.45

21 January 2018

Identifiers

DOI

10.1038/LEU.2010.45

1 reference

Dimensions Publication ID

14 November 2017

1034470392

0 references

1 reference